Study Details

Back
Study ID 06003/TnIO01
Study Title A Double-blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacyand Safety of Ramosetron Plus Dexamethasone Injection for the Prevention of Chemotherapy inducedVomiting and Nausea
Clinicaltrials.gov Identifier NCT00272285
Compound Name YM060 / ramosetron hydrochloride
Medical Indication or Disease Antineoplastic drug-induced nausea and vomiting
Study Sponsor Astellas Pharma Taiwan, Inc.
Collaborator Not Applicable
Study Start Date 16-Jan-2006
Study Completion Date 17-Dec-2007
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS